Home / Resource Library / Preliminary Results of a Phase II Study of Lenalidomide Combined with Immunochemotherapy in Patients with Primary Central Nervous System Lymphoma
Preliminary Results of a Phase II Study of Lenalidomide Combined with Immunochemotherapy in Patients with Primary Central Nervous System Lymphoma